The complexity of microenvironment-mediated drug resistance

Genes and Cancer

Volumn 6, Issue 9-10, 2015, Pages 367-368

  Fedorenko, Inna V ^a   Smalley, Keiran S M ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

Drug resistance; Fibroblasts; Host; Melanoma; Microenvironment

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; B RAF KINASE INHIBITOR; FIBRONECTIN; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; VEMURAFENIB;

APOPTOSIS; FIBROBLAST; GENE EXPRESSION; HUMAN; MELANOMA; NOTE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84945927868     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: None     Document Type: Note

References (7)

1. Spagnolo F, et al. Oncotarget. 2014; 5: 10206-10221.
2. Wilson TR, et al. Nature. 2012; 487: 505-509.
3. Straussman R, et al. Nature. 2012; 487: 500-U118.
4. Fedorenko IV, et al. Oncogene. 2015; doi: 10.1038/onc.2015.
5. Fedorenko IV, et al. J Invest Dermatol. 2015; doi:10.1038/jid.2015.329.
6. Hirata E, et al. Cancer Cell. 2015; 27:574-588.
7. Capparelli C, et al. J Biol Chem. 2015; 290: 24267-77.